Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-034531
Filing Date
2011-06-03
Accepted
2011-06-03 09:00:30
Documents
1
Period of Report
2011-06-01

Document Format Files

Seq Description Document Type Size
1 rrd312776.html 4  
1 rrd312776.xml 4 7545
  Complete submission text file 0001181431-11-034531.txt   9013
Mailing Address C/O AEGERION PHARMACEUTICALS 89 HEADQUARTERS PLAZA, SUITE 1212 MORRISTOWN NJ 07960
Business Address
Beer Marc D (Reporting) CIK: 0001314575 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34921 | Film No.: 11890276

Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations